A pharmacokinetic analysis of a novel enzyme replacement therapy with Gene-Activated human glucocerebrosidase (GA-GCB) in patients with type 1 Gaucher disease.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples